The Government Accountability Office, the agency that keeps a close eye on government integrity, says the FDA ought to be doing a much better job of regulating dietary supplements. It grants that the FDA has taken “some” or “limited” action to go after potentially unsafe products, of which, apparently, there are plenty. The agency, it says, cannot do its job because it lacks resources and recall authority and gives supplements too low a priority.
This is old news, but the report provides an excellent summary of the history and current status of the dietary supplement industry and its regulation. As is typical of GAO reports, the clarity of presentation is exceptional. Here’s what the New York Times reporter says about it.